Dr. Reddy's Laboratories is currently trading at Rs. 2231.00, up by 36.85 points or 1.68% from its previous closing of Rs. 2194.15 on the BSE.
The scrip opened at Rs. 2219.00 and has touched a high and low of Rs. 2240.05 and Rs. 2201.90 respectively. So far 28633 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 2948.00 on 01-Mar-2017 and a 52 week low of Rs. 1901.65 on 11-Aug-2017.
Last one week high and low of the scrip stood at Rs. 2,240.05 and Rs. 2080.00 respectively. The current market cap of the company is Rs. 36944.49 crore.
The promoters holding in the company stood at 26.76%, while Institutions and Non-Institutions held 44.63% and 15.19% respectively.
Dr. Reddy’s Laboratories has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its formulations facility at Srikakulam in the state of Andhra Pradesh.
USFDA has maintained Official Action Indicated (OAI) status at its API manufacturing plant at Srikakulam.
Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1528.20 |
Dr. Reddys Lab | 5872.35 |
Cipla | 1405.95 |
Zydus Lifesciences | 997.45 |
Lupin | 1638.40 |
View more.. |